UNH
UNH
$425.36-0.28%
Setup
Base breakout
Buy Zone
$442.16-$464.27
Sector
—
Industry
—
57
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
UNH chart
Loading chart…
Overall Quality57
RS Rating
69
relative strength
Fundamentals
45
Weak fund-Q
Volume Demand
45
-49% vs avg
Technical Setup
88
7/8 checks
Industry/Theme
91
Computer Software-Enterprise
Trade Plan
Avoid
Entry
$442.16
Entry Zone
$442.16-$464.27
Stop / Risk
$406.79
RS Rating
69
Volume confirmed
No
Targets
$530.59 / $552.7
Breakout · IBD Setup
4 ✓ 4 ✗
Entry $442.16–$464.27Stop $406.79Target $530.59 / $552.7
Market regimeRange
Quality57
RS Rating69
Above 50-MA+8.94%
Above 200-MA+26.11%
VolumeWeak
In Buy ZoneYes
Not extendedOK
Invalidation · Close below stop
How this came together
57
MarketRange
SetupBase breakout
ConfidenceExperimental · not backtested
Fund-Q45 · Weak
StatusAvoid
Stock Data
52-Week Range235 – 428
Price % Chg YTD28.85%
Price % Chg 4wk12.55%
50-Day Avg Vol7.7 Mil
P/E Ratio—
Market Cap$717B
Sector—
Industry—
Company Fundamentals
EPS % Chg (Qtr)—
Sales % Chg (Qtr)—
EPS Growth 5y—
Sales Growth 5y—
Annual ROE—
Gross Margin—
Operating Margin—
Net Margin—
Debt / Equity—
Setup levels
Current price
$425.36
Pivot
$442.16
Distance to buy
-0.6%
52-week range
234.6-428.01
Trigger evidence
No active trigger evidence available.
Financial health checks
0/0
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE—
Net margin—
Gross margin—
EPS growth q/q—
Sales growth q/q—
Debt / equity—
lower is better
Business quality
45
GradeWeak
EPS rating50
P/E—
Market cap$717B
Industry—
Technical checks
Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Pass
Volumen bestätigt
Fail
In Kaufzone
Pass
Nicht überextended
Pass
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
WATCHLIST_ONLY2026-06-2600:13:10
Looks like it wants to move higher, indicating money flowing into healthcare, but the speaker does not intend to trade it.
Signal history
Added to list
2026-06-28
Trigger date
—
Days on list
6
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.